Results 251 to 260 of about 11,548,225 (392)
Ethical Aspects of Intertemporal Discounting and the Social Discount Rate
Márta Somogyvári
openalex +1 more source
Osteosarcoma is the most common primary bone tumor with limited treatment options and a terrible prognosis. This review provides a comprehensive summary of the recent development of osteoimmunomodulatory implants for post‐operative osteosarcoma treatment, of which the potential utility in evoking durable anti‐osteosarcoma immunity and accelerating bone
Yilong Dong +6 more
wiley +1 more source
Methodological guidelines for Health Technology Assessment in Oman. [PDF]
Wani S +30 more
europepmc +1 more source
What Discount Rate Should Bankruptcy Judges Use? Estimate from Canadian Reorganization Data
Fabrice Barthélémy +2 more
openalex +1 more source
A simultaneous approach to the estimation of risk aversion and the subjective time discount rate
Adam S. Booij, Bernard M. S. van Praag
openalex +2 more sources
Identifying disease‐causing genes in neurocognitive disorders remains challenging due to variants of uncertain significance. CLinNET employs dual‐branch neural networks integrating Reactome pathways and Gene Ontology terms to provide pathway‐level interpretability of genomic alterations.
Ivan Bakhshayeshi +5 more
wiley +1 more source
High-resolution global pathways to achieve 100% electricity access in 2030. [PDF]
Zapata V +3 more
europepmc +1 more source
Single‐cell sequencing reveals stress‐programmed immune states driving TNFα–TNFR2–mediated Treg activation and therapy resistance in breast cancer, while targeting this axis restores antitumor immunity. ABSTRACT The tumor microenvironment (TME) harbors diverse immune cell states that shape therapeutic outcomes in breast cancer.
Zhibo Shao +18 more
wiley +1 more source
The economic burden of COVID-19 premature mortality in Kuwait. [PDF]
Almari M, O'Neill S, Sadique Z.
europepmc +1 more source

